Cogent Biosciences (COGT) Shares Issued (2017 - 2026)
Cogent Biosciences (COGT) posted quarterly Shares Issued of $1.1 million for Q1 2026, down 34.07% year-over-year from $1.7 million in Q1 2025, and down 15.1% quarter-over-quarter from $1.4 million in Q4 2025.
Cogent Biosciences (COGT) Shares Issued (2017 - 2026) Analysis & Trends
Cogent Biosciences (COGT) has reported Shares Issued for 10 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Issued fell 34.07% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (down 34.07% YoY), while the FY2025 annual figure was $1.4 million, down 93.71% from the prior year.
- Shares Issued retreated to $1.1 million in Q1 2026 per COGT's latest filing, from $1.4 million in the prior quarter.
- Across five years, Shares Issued topped out at $21.5 million in Q4 2024 and bottomed at $442924.0 in Q2 2022.
- Historically, Shares Issued has averaged $3.9 million across 5 years, with a median of $1.1 million in 2026.
- Annual changes were most pronounced in 2023 — Shares Issued soared 808.16% — and 2025, when it sank 93.71%.
- Cogent Biosciences' Shares Issued stood at $12.8 million in 2022, then grew by 20.82% to $15.5 million in 2023, then soared by 38.67% to $21.5 million in 2024, then tumbled by 93.71% to $1.4 million in 2025, then retreated by 15.1% to $1.1 million in 2026.
- Business Quant data shows COGT's Shares Issued at $1.1 million in Q1 2026, $1.4 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Cogent Biosciences | 6.58 Bn | 6.58 Bn | - | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.00 Mn |
| Jun 30, 2026 | 2.00 Mn |
| Mar 31, 2026 | 1.15 Mn |
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | 1.67 Mn |
| Sep 30, 2025 | 1.67 Mn |
| Jun 30, 2025 | 1.61 Mn |
| Jun 30, 2025 | 1.61 Mn |
| Mar 31, 2025 | 1.74 Mn |
| Mar 31, 2025 | 1.74 Mn |
| Dec 31, 2024 | 21.50 Mn |
| Dec 31, 2024 | 21.50 Mn |
| Sep 30, 2024 | 577,995.00 |
| Sep 30, 2024 | 577,995.00 |
| Jun 30, 2024 | 677,995.00 |
| Jun 30, 2024 | 677,995.00 |
| Mar 31, 2024 | 677,995.00 |
| Mar 31, 2024 | 677,995.00 |